Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial

BACKGROUND: Consensus interferon (CIFN) is a newly developed type I interferon. AIMS: This multicentre, controlled trial was conducted to determine the efficacy of CIFN and to compare it with alpha-1b-interferon (IFN-α1b) in the treatment of patients with hepatitis B e antigen (HBeAg)-positive chron...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, YongLi, Zhao, LianSan, Wu, TaiXiang, Guo, ShuHua, Chen, YaGang, Zhou, TaoYou
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715390/
https://www.ncbi.nlm.nih.gov/pubmed/19586556
http://dx.doi.org/10.1186/1743-422X-6-99

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715390/
https://www.ncbi.nlm.nih.gov/pubmed/19586556
http://dx.doi.org/10.1186/1743-422X-6-99

Ejemplares similares